Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633971 · ClinicalTrials.gov registry record · NA
Treatment Trial for Post-Thrombotic Syndrome
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00633971 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 31 participants.
The verdict
NCT00633971, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.
Interventions
- OTHER complex lymphedema therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00633971
The ClinicalTrials.gov registry entry for NCT00633971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which complex lymphedema therapy is the first listed.
NCT00633971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00633971 about?
NCT00633971 is a clinical study titled "Treatment Trial for Post-Thrombotic Syndrome". The purpose of this study is to determine if complex lymphedema therapy is effective in decreasing disease severity and improving quality of life in patients with post thrombotic syndrome.
What is the current status of trial NCT00633971?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2008-03. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00633971?
The interventions under investigation include: complex lymphedema therapy (OTHER).
Who is sponsoring clinical trial NCT00633971?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.